meta_pixel
Tapesearch Logo
Log in
Public Health On Call

497 - Juul vs. The FDA: The Failed Promise of E-Cigarettes

Public Health On Call

The Johns Hopkins Bloomberg School of Public Health

News, Health & Fitness, Medicine

4.6644 Ratings

🗓️ 27 July 2022

⏱️ 20 minutes

🧾️ Download transcript

Summary

The FDA recently issued a marketing denial order for all Juul products, which was quickly reversed when Juul filed for a temporary stay. Dr. Joanna Cohen talks with Stephanie Desmon about why e-cigarettes are regulated like cigarettes and not pharmaceuticals despite their initial introduction to the market as a smoking cessation tool, where gains have been made in reducing popularity with youths, and why other tools like nicotine replacement therapy have not been able to live up to their promise to help more people quit smoking.

Transcript

Click on a timestamp to play from that location

0:00.0

Welcome to Public Health On Call, a podcast from the Johns Hopkins Bloomberg School of Public Health.

0:12.0

I'm Joshua Sharfstein, Vice Dean for Public Health Practice and Community Engagement,

0:16.9

and a former health commissioner here in Baltimore.

0:19.7

Our goal is to bring evidence and experience to illuminate critical public health issues.

0:25.4

If you have questions or ideas for us, please send an email to public health question at jhhhu.edu.

0:31.5

That's public health question at jh.hu.edu for future podcast episodes.

0:37.6

Hi, I'm Lindsay Smith-Rogers, producer of Public Health on Call.

0:41.4

Today, Stephanie Desmond talks to Joanna Cohen, who directs the Institute for Global Tobacco Control at Johns Hopkins,

0:48.1

about recent news regarding e-cigarettes and whether some brands will be taken off the shelves

0:53.6

for good under new FDA regulations.

0:56.8

Let's listen.

0:58.2

Joanna Cohen, thanks so much for joining me.

1:00.2

My pleasure.

1:01.4

Today, I want to talk to you about the e-cigarettes situation in this country.

1:07.9

There's been a lot of news about restrictions, about whether they're,

1:14.8

you know, are they good for us? Are they bad for us? Could you just sort of lay out the landscape

1:18.5

for us here? Yeah, that's a great question because it has been complicated and a lot has happened

1:24.7

since e-cigarettes came onto the market in 2006, so quite some time ago.

1:31.4

And what's really fascinating is that originally the FDA wanted to regulate e-cigarettes like

1:39.4

smoking cessation drugs. And they were actually sued by any cigarette company. So we don't want to be

1:48.8

regulated like as a pharmaceutical product. We want to be regulated more like cigarettes. And of course,

1:55.7

they wanted that because cigarettes aren't very regulated. So it's a lot easier for them to, you know, cigarettes are a

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from The Johns Hopkins Bloomberg School of Public Health, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Johns Hopkins Bloomberg School of Public Health and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.